Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Virginia Guzikowski"'
Autor:
Silvia Pires Lourenco, Danuta Jarocha, Valentina Ghiaccio, Amaliris Guerra, Osheiza Abdulmalik, Ping La, Alexandra Zezulin, Kim Smith-Whitley, Janet L. Kwiatkowski, Virginia Guzikowski, Yukio Nakamura, Tobias Raabe, Laura Breda, Stefano Rivella
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/af3ad5908f5d468bbcfda257356590f8
Autor:
Danuta Jarocha, Janet L. Kwiatkowski, Tobias Raabe, Virginia Guzikowski, Silvia Pires Lourenco, Stefano Rivella, Yukio Nakamura, Amaliris Guerra, Kim Smith-Whitley, Alexandra Zezulin, Laura Breda, Ping La, Valentina Ghiaccio, Osheiza Abdulmalik
Publikováno v:
Haematologica. 106:2740-2745
Autor:
Tobias Raabe, Janet L. Kwiatkowski, Aoife M. Doto, Alisa Dong, Frederic D. Bushman, Charles A. Assenmacher, Enrico Radaelli, John K. Everett, Carla Casu, Danuta Jarocha, Kim Smith-Whitley, Osheiza Abdulmalik, Xiaochuan Shan, Laura Breda, James C. Tarrant, Yasuhiro Ikawa, Ryo Kurita, Virginia Guzikowski, Gwenn Danet-Desnoyers, Naoto Tanaka, Natalie Hoepp, Stefano Rivella, Yukio Nakamura, Valentina Ghiaccio
Publikováno v:
Mol Ther
Ongoing clinical trials for treatment of beta-globinopathies by gene therapy involve the transfer of the beta-globin gene, which requires integration of three to four copies per genome in most target cells. This high proviral load may increase genome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb268911a830997d4bc834d262854d0c
https://europepmc.org/articles/PMC8058492/
https://europepmc.org/articles/PMC8058492/
Autor:
Silvia, Pires Lourenco, Danuta, Jarocha, Valentina, Ghiaccio, Amaliris, Guerra, Osheiza, Abdulmalik, Ping, La, Alexandra, Zezulin, Kim, Smith-Whitley, Janet L, Kwiatkowski, Virginia, Guzikowski, Yukio, Nakamura, Tobias, Raabe, Laura, Breda, Stefano, Rivella
Publikováno v:
Haematologica
Autor:
Naoto Tanaka, Silvia Pires Lourenco, Danuta Jarocha, Valentina Ghiaccio, Carla Casu, Kim Smith-Whitley, Virginia Guzikowski, Stefano Rivella, Laura Breda, Yasuhiro Ikawa, Janet L. Kwiatkowski
Publikováno v:
Blood. 134:2242-2242
The ongoing clinical trials, based on the use of lenti-globin vectors for beta-globinopathies, indicate that current vectors require high number of integrations (~3-4 copies per genome) in a pancellular fashion to make a patient transfusion independe
Autor:
Valentina Ghiaccio, Yukio Nakamura, Vanessa Carrion, Laura Breda, Ryo Kurita, Janet L. Kwiatkowski, Stefano Rivella, Carla Casu, Silvia Pires Lourenco, Virginia Guzikowski, Hanyia Zaidi, Kim Smith-Whitley
Publikováno v:
Blood. 132:3477-3477
Given that both Sickle Cell Disease (SCD) and beta-thalassemia (BT) are caused by mutations in the beta-globin gene, several lentivirus-based gene addition therapies have been developed. Results from recent trials indicate that the vectors used are s
Autor:
Samuel B. Goldfarb, Jorge H. Baluarte, Virginia Guzikowski, Kim M. Olthoff, Kevin E.C. Meyers, Elizabeth R. Rand, Nancy Bunin
Publikováno v:
Pediatric Transplantation. 14:1030-1035
SOT may be indicated for a select group of pediatric patients who experience permanent organ failure following HSCT. However, there is limited information available about outcomes. We identified eight children at our center who received an SOT follow
Autor:
Nancy, Bunin, Virginia, Guzikowski, Elizabeth R, Rand, Samuel, Goldfarb, Jorge, Baluarte, Kevin, Meyers, Kim M, Olthoff
Publikováno v:
Pediatric transplantation. 14(8)
SOT may be indicated for a select group of pediatric patients who experience permanent organ failure following HSCT. However, there is limited information available about outcomes. We identified eight children at our center who received an SOT follow
Publikováno v:
Pediatric Oncology ISBN: 3540408401
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ac8f93d6b776171427a902a7905d9b6
https://doi.org/10.1007/3-540-26498-1_17
https://doi.org/10.1007/3-540-26498-1_17